Position in INSM
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$106
New position
Shares Held
1
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#660
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cordant, Inc. holds $3,783 across 10 Biotechnology names. INSM ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
10 | $930 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
16 | $915 | |
| 3 | MRNA |
Moderna, Inc.
|
10 | $700 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
10 | $545 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1 | $301 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
3 | $170 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
2 | $116 | |
| 8 | INSM |
INSMED Inc
This page
|
1 | $106 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106 | 1 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||